Treating multiple sclerosis costs a great deal for patients and communities. Individually, the nearly 1 million people with MS pay an average annual cost of more than $88,000 for the various treatment options, devices, daily living needs, and insurance needed for their condition. Overall, indirec...
Mitoxantrone (Novantrone) is achemotherapyagent that has been approved by the FDA to treat multiple sclerosis. Treatment with mitoxantrone requires monitoring of cardiac function, and there is a fixed limit to the dose that can be administered to patients. It also carries the long-term risk ofl...
MULTIPLE sclerosis (MS) is an autoimmune neurological condition diagnosed in 3.5 to 6.6 people per 100,000 of the population each year — equivalent to between 1,800 and 3,400 people in England and Wales. It is mostly diagnosed between the ages of 20 and 40 years and there are roughly ...
Tailored ways to manage multiple sclerosis and its symptoms While there’s no cure for MS, many treatment options make it possible to manage the symptoms and slow the progression of this condition. MS is different for everyone, so most care plans are highly personalized, often combining elements...
Children and teens with multiple sclerosis are treated with the same therapies as adults, but they are considered “off label” for treating children, (not an FDA approved the use of the drug, but it is/may be effective for some people with the condition). Small studies suggest the IV dru...
Is multiple sclerosis curable? Currently, there is no cure for multiple sclerosis, but the condition can be managed with appropriate treatment, and lifestyle modifications to avoid triggers. Treatment can help relieve symptoms, prolong remission periods, slow down disease progression and limit disabilit...
Get the latest multiple sclerosis news, patient views, and caregiver perspectives from one of the largest MS communities online.
Despite important advances in the treatment of multiple sclerosis (MS) over recent years, the introduction of several disease-modifying therapies (DMTs), the burden of progressive disability and premature mortality associated with the condition remains substantial. This burden, together with the high hea...
Multiple Sclerosis is a disease of he the central nervous system that interrupts the communication between the brain and the body. Keep reading to learn more about MS.
This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition resulting in devastating social and economic impacts. As MS can affect any part of the central nervous system, the presentation is often diverse; however, there are key featu...